Montemagno, C.; Cassim, S.; Pouyssegur, J.; Broisat, A.; Pagès, G.
From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma. Int. J. Mol. Sci. 2020, 21, 4067.
https://doi.org/10.3390/ijms21114067
AMA Style
Montemagno C, Cassim S, Pouyssegur J, Broisat A, Pagès G.
From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. 2020; 21(11):4067.
https://doi.org/10.3390/ijms21114067
Chicago/Turabian Style
Montemagno, Christopher, Shamir Cassim, Jacques Pouyssegur, Alexis Broisat, and Gilles Pagès.
2020. "From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma" International Journal of Molecular Sciences 21, no. 11: 4067.
https://doi.org/10.3390/ijms21114067
APA Style
Montemagno, C., Cassim, S., Pouyssegur, J., Broisat, A., & Pagès, G.
(2020). From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences, 21(11), 4067.
https://doi.org/10.3390/ijms21114067